Johnson & Johnson’s TAR-200 Granted FDA Breakthrough Status for High-Risk Bladder Cancer
Johnson & Johnson received FDA Breakthrough Therapy Designation (BTD) for TAR-200, a promising treatment for high-risk non-muscle-invasive bladder cancer (HR-NMIBC) patients unsuitable for radical...
Experts Raise Implementation Concerns for IRA-Mandated Medicare Drug Price Negotiation
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, recently published two groundbreaking commentaries focusing on the...
Anticipated Growth in the Pharmaceutical Excipients Market
According to a report by MarketsandMarkets, the pharmaceutical excipients market is projected to experience substantial growth, reaching an estimated value of $14.9 billion by...
Approval Granted for Innovative Generalized Myasthenia Gravis Treatment
The European Commission (EC) has given its authorization for ZILBRYSQ® (zilucoplan), a once-daily subcutaneous (SC) C5 complement inhibitor, making it the initially targeted peptide...
InEK Releases Germany’s 2024 DRGs Catalog for Hospital Remuneration
On November 14, 2023, the Institute for the Hospital Remuneration System (InEK) released the eagerly anticipated Diagnosis-Related Groups (DRGs) catalog for 2024, outlining notable...
Roche’s Merger Deal: Acquiring Carmot Therapeutics’ Potent Assets in Diabetes and Obesity
Roche, a global leader in healthcare, has announced a definitive merger agreement with Carmot Therapeutics, a prominent US-based biotech company specializing in metabolic disease...
Assessing Alternative Approaches to Resource Allocation in Healthcare
The quality-adjusted life year (QALY) has faced criticism for its bias toward shorter life extensions and limited consideration for health-related quality of life (HRQoL)....
Challenges in Battling Falsified Medical Devices and Calls for Awareness
The Committee of Experts on Minimizing Public Health Risks associated with counterfeit medical products and related offenses (CD-P-PH/CMED) released a report shedding light on...
Sanofi’s Consumer Healthcare Unveils Shared Care Collective to Drive Sustainability Initiatives
Sanofi’s Consumer Healthcare business unit unveiled the Shared Care Collective, a groundbreaking initiative launched on December 1, 2023. This pioneering advisory board comprises a...
FDA Initiates Evaluation of Padcev/Keytruda Combination for Bladder Cancer Treatment
The Food and Drug Administration (FDA) has commenced a priority assessment of a novel combined treatment for previously untreated, advanced forms of urothelial carcinoma...
Enhanced Governmental Funding Allocated to Cancer Care in Denmark
The Danish government's allocation of an additional 300 million DKK in 2024 aimed to bolster the nation's cancer care services, marking a crucial step...
Fresh Insights and Recommendations from CADTH on Emergency Department Overcrowding
CADTH (Canada's Drug and Health Technology Agency) has recently released an extensive body of evidence and guidance aimed at addressing the critical issue of...
Advancing Hematology Science: AstraZeneca’s Presence at ASH 2023
AstraZeneca, in conjunction with Alexion, will unveil a breadth of data spanning 63 abstracts at the 65th American Society of Hematology (ASH) Annual Meeting...
Singapore’s Thriving Pharmaceutical and Healthcare Landscape: Innovations and Collaborations
Singapore is bustling with significant pharmaceutical advancements, with various key players making notable strides in the industry. The recent pharma news encompasses several groundbreaking...
UK’s £100 Million Investment in AI for Targeted Health Solutions
The UK Government has allocated £100 million towards the "AI Life Sciences Accelerator Mission," aiming to propel AI utilization in life sciences and address...
